Get started
Author

Ecaterina E. Ileana

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2017 · Christophe Massard, Stefan Michiels, et al. · Cancer Discovery · 783
Targeting FGFR Signaling in Cancer
2015 · Mehdi Touat, Ecaterina Ileana, et al. · Clinical Cancer Research · 528
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
2016 · Cécile Jovelet, Ecaterina Ileana, et al. · Clinical Cancer Research · 123
Incorporating Immune-Checkpoint Inhibitors into Systemic Therapy of NSCLC
2014 · Stéphane Champiat, Ecaterina Ileana, et al. · Journal of Thoracic Oncology · 96
Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer
2015 · Yohann Loriot, Jean-Christophe Eymard, et al. · European Journal of Cancer · 77
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)
2016 · Vania Tacher, Marie-Cécile Le Deley, et al. · European Journal of Cancer · 48
Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon?
2010 · Ecaterina Ileana, Laurent Greillier, et al. · Lung Cancer · 26
Immune-Checkpoints : les nouvelles immunothérapies anticancéreuses
2013 · Ecaterina Ileana, Stéphane Champiat, et al. · Bulletin du Cancer · 15
Abstract CT240: Molecular screening for cancer treatment optimization (MOSCATO 01): a prospective molecular triage trial; Interim analysis of 420 patients
2014 · Charles Ferté, Christophe Massard, et al. · Cancer Research · 14
Abiraterone in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and MDV3100.
2012 · Ecaterina Ileana, Yohann Loriot, et al. · Journal of Clinical Oncology · 12
From Uniplex to Multiplex Molecular Profiling in Advanced Non–Small Cell Lung Carcinoma
2015 · Ecaterina E. Ileana, Ignacio I. Wistuba, et al. · The Cancer Journal · 3
Abstract 2401: Circulating cell-free tumor DNA (cfDNA) analysis of 50-genes by next-generation sequencing (NGS) in the prospective MOSCATO trial
2015 · Ecaterina Ileana, Cécile Jovelet, et al. · Cancer Research · 3
Prognostic factors and outcome of patients with hematological malignancies in phase I trials
2017 · Lina Benajiba, Jean-Marie Michot, et al. · Anti-Cancer Drugs · 2
Effects of abiraterone acetate and enzalutamide on muscle and adipose mass in men with metastatic castration-resistant prostate cancer (mCRPC).
2013 · Ecaterina Ileana, Sami Antoun, et al. · Journal of Clinical Oncology · 1
Supplementary Figure Legends from High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2023 · Christophe Massard, Stefan Michiels, et al.
Supplementary Figure 2 from High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2023 · Christophe Massard, Stefan Michiels, et al.
Supplementary Figure 1 from High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2023 · Christophe Massard, Stefan Michiels, et al.
Supplementary Methods from High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2023 · Christophe Massard, Stefan Michiels, et al.
PDF
Supplementary Figure 2 from High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2023 · Christophe Massard, Stefan Michiels, et al.
PDF
Data from High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2023 · Christophe Massard, Stefan Michiels, et al.
Supplementary Table 1 from Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
2023 · Cécile Jovelet, Ecaterina Ileana, et al.
Supplementary Figure 1 from Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
2023 · Cécile Jovelet, Ecaterina Ileana, et al.
Data from Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
2023 · Cécile Jovelet, Ecaterina Ileana, et al.
Data from Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
2023 · Cécile Jovelet, Ecaterina Ileana, et al.
Abstract 1144: Detection of a novel ALK fusion variant in lung adenocarcinoma using a comprehensive genomic analysis
2016 · Kazuhiko Shien, Dennis Ruder, et al. · Cancer Research
Works count: 26
Citation count: 1,731
H-index: 10
I10-index: 10
Year
Topic
Type